Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/75042
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ojeda, Soledad | en_US |
dc.contributor.author | Pan, Manuel | en_US |
dc.contributor.author | Martin, Pedro | en_US |
dc.contributor.author | Mazuelos, Francisco | en_US |
dc.contributor.author | Suarez de Lezo, Javier | en_US |
dc.contributor.author | Romero, Miguel | en_US |
dc.contributor.author | Segura, Jose | en_US |
dc.contributor.author | Pavlovic, Djordje | en_US |
dc.contributor.author | Medina, Alfonso | en_US |
dc.contributor.author | Suarez de Lezo, Jose | en_US |
dc.date.accessioned | 2020-10-27T13:38:00Z | - |
dc.date.available | 2020-10-27T13:38:00Z | - |
dc.date.issued | 2014 | en_US |
dc.identifier.issn | 1936-8798 | en_US |
dc.identifier.other | WoS | - |
dc.identifier.uri | http://hdl.handle.net/10553/75042 | - |
dc.description.abstract | Objectives The goal of this study was to assess the immediate and long-term outcomes in patients undergoing percutaneous coronary intervention (PCI) for in-stent restenosis (ISR) in an unprotected distal left main coronary artery (UDLM).Background PCI for UDLM-ISR can be complex. Limited information is available on procedural and clinical outcomes. Methods Between May 2002 and February 2011, UDLM-ISR after drug-eluting stent implantation was observed in 79 of 1,102 patients (7%). Seventy-five were treated by repeat PCI using a simple approach (balloon/in-stent implantation) or a complex strategy (additional stent/double-stenting technique). A diagnosis of mild or severe restenosis was considered depending on the number of bifurcation segments affected (1 vs. >1). Major adverse cardiac events (MACE) were defined as cardiac death, target lesion revascularization, and myocardial infarction.Results ISR treatment was performed using a simple approach in 44 (58%) patients, and using a complex strategy in 31 (42%). After 46 +/- 26 months, the MACE rate was 22%. Patients treated with a simple approach had a lower incidence of MACE at follow-up compared with patients treated with a complex strategy, regardless of the restenosis extent (mild restenosis: 93% vs. 67%, p < 0.05; severe: 70% vs. 23%, p < 0.05). On Cox regression analysis, diabetes was the only predictor of MACE (hazard ratio [HR]: 4.94; 95% confidence interval [CI]: 1.03 to 23.70; p < 0.05), whereas a simple strategy for ISR treatment was associated with lower risk (HR: 0.25; 95% CI: 0.08 to 0.79; p = 0.02).Conclusions PCI for UDLM-ISR is safe and feasible, with a high rate of procedural success and an acceptable long-term MACE rate. A simple strategy, when applicable, appears to be a good treatment option, associated with a lower event rate at follow-up. (C) 2014 by the American College of Cardiology Foundation | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | JACC: Cardiovascular Interventions | en_US |
dc.source | Jacc-Cardiovascular Interventions [ISSN 1936-8798], v. 7 (2), p. 212-221, (Febrero 2014) | en_US |
dc.subject | 320501 Cardiología | en_US |
dc.subject | 320704 Patología cardiovascular | en_US |
dc.subject | 321307 Cirugía del corazón | en_US |
dc.subject.other | Coronary-Artery-Disease | en_US |
dc.subject.other | Drug-Eluting Stent | en_US |
dc.subject.other | Bypass-Surgery | en_US |
dc.subject.other | Bifurcation Lesions | en_US |
dc.subject.other | Intervention | en_US |
dc.subject.other | Stenosis | en_US |
dc.subject.other | Implantation | en_US |
dc.subject.other | Angioplasty | en_US |
dc.subject.other | Predictors | en_US |
dc.subject.other | Cardiology | en_US |
dc.subject.other | Bifurcation Lesion | en_US |
dc.subject.other | Drug-Eluting Stent(S) | en_US |
dc.subject.other | Left Main | en_US |
dc.subject.other | Restenosis | en_US |
dc.title | Immediate Results and Long-Term Clinical Outcome of Patients With Unprotected Distal Left Main Restenosis The CORPAL Registry (Cordoba and Las Palmas) | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.jcin.2013.06.017 | en_US |
dc.identifier.scopus | 84894343234 | - |
dc.identifier.isi | 000331719900023 | - |
dc.contributor.authorscopusid | 8654250900 | - |
dc.contributor.authorscopusid | 7202544866 | - |
dc.contributor.authorscopusid | 7406037925 | - |
dc.contributor.authorscopusid | 24450657100 | - |
dc.contributor.authorscopusid | 16067353500 | - |
dc.contributor.authorscopusid | 7202430759 | - |
dc.contributor.authorscopusid | 55415591100 | - |
dc.contributor.authorscopusid | 7005198171 | - |
dc.contributor.authorscopusid | 7202723590 | - |
dc.contributor.authorscopusid | 7006785516 | - |
dc.identifier.eissn | 1876-7605 | - |
dc.description.lastpage | 221 | en_US |
dc.identifier.issue | 2 | - |
dc.description.firstpage | 212 | en_US |
dc.relation.volume | 7 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.contributor.daisngid | 343824 | - |
dc.contributor.daisngid | 77557 | - |
dc.contributor.daisngid | 1673863 | - |
dc.contributor.daisngid | 452208 | - |
dc.contributor.daisngid | 67522 | - |
dc.contributor.daisngid | 156230 | - |
dc.contributor.daisngid | 1825688 | - |
dc.contributor.daisngid | 831427 | - |
dc.contributor.daisngid | 74576 | - |
dc.contributor.daisngid | 476437 | - |
dc.description.numberofpages | 10 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Ojeda, S | - |
dc.contributor.wosstandard | WOS:Pan, M | - |
dc.contributor.wosstandard | WOS:Martin, P | - |
dc.contributor.wosstandard | WOS:Mazuelos, F | - |
dc.contributor.wosstandard | WOS:de Lezo, JS | - |
dc.contributor.wosstandard | WOS:Romero, M | - |
dc.contributor.wosstandard | WOS:Segura, J | - |
dc.contributor.wosstandard | WOS:Pavlovic, D | - |
dc.contributor.wosstandard | WOS:Medina, A | - |
dc.contributor.wosstandard | WOS:de Lezo, JS | - |
dc.date.coverdate | Febrero 2014 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.description.sjr | 5,249 | |
dc.description.jcr | 7,345 | |
dc.description.sjrq | Q1 | |
dc.description.jcrq | Q1 | |
dc.description.scie | SCIE | |
item.grantfulltext | open | - |
item.fulltext | Con texto completo | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Morfología | - |
crisitem.author.orcid | 0000-0002-2378-3242 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Martín Rodríguez, Patricia | - |
Appears in Collections: | Artículos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.